Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From Poxel SA

Dainippon’s Lead Boston Asset Hits Wall In Pancreatic Cancer

Dainippon Sumitomo suffers major Phase III setback for one of its key oncology prospects, and although the former Boston Biomedical asset will carry on in other planned indications, the Japanese firm may have to look for ways to fill the gap.

Clinical Trials Cancer

Positive Phase III Data Set Stage For Japan Imeglimin Filing

Partners Poxel and Sumitomo Dainippon confirm Japan filing plans for novel glimin antidiabetic following positive top-line Phase III results, and cast an eye towards market positioning.

Japan Clinical Trials

Deal Watch: Mylan Clears Up Mystery, Acquires TOBI Cystic Fibrosis Products From Novartis

Having previously disclosed in an SEC filing that it acquired a commercial product, Mylan announces it bought TOBI Podhaler for $463m. Biohaven completes second licensing deal with AstraZeneca, while struggling United Therapeutics and MannKind team up.

Deals Business Strategies

Poxel Adds To NASH Pipeline With Novel Single-Isomer Pioglitazone

Some ground-breaking chemistry has been used to produce a single isomer of pioglitazone, which has been acquired by France's Poxel to evaluate in NASH, adding to its portfolio of potential metabolic disease therapies.

 

Deals Metabolic Disorders
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Hepatic (Liver)
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Poxel SA
  • Senior Management
  • Thomas Kuhn, CEO
    Anne Renevot, CFO
    Noan Beerman, EVP, Bus. Dev. & Pres., US Operations
    Pascale Malgouyres, EVP, Commercial Dev.
    Christophe Arbet-Engels, MD, PhD, CMO & EVP, Late Dev. & Medical Affairs
    Iman Barilero, PhD, SVP & Global Head, Reg. Affairs
  • Contact Info
  • Poxel SA
    Phone: (33) 437 372 012
    259-261 avenue Jean Jaurès
    Lyon, 69007
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register